Asthenospermia. male infertility
Conditions
Interventions
Intervention 1: Control group:Placebo placebo: Lactose, 12 weeks, 3 capsule(500 mg) per day. Intervention 2: Curcumin acid 80 mg per day for 12 weeks, 2 capsule per day(40 mg). Intervention 3: Interve
Placebo
Treatment - Drugs
Control group:Placebo placebo: Lactose, 12 weeks, 3 capsule(500 mg) per day
Curcumin acid 80 mg per day for 12 weeks, 2 capsule per day(40 mg)
Intervention group:carob 500 mg per day for 12 weeks, 3 capsule per day(500 mg)
Intervention group:Propolis acid 600 mg per day for12 weeks, 3 capsule per day(500 mg)
Sponsors
Deputy for Research Qazvin University of Medical Sciences
Eligibility
Sex/Gender
Male
Age
25 Years to 45 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Willing to participate in the study ; Passing at least a year since the decision to child bearing (no conception after 12 months intercourse without any contraception); age 20-45 y.o; idiopathic asthenospermia according to WHO criteria; normal levels of gonadotropins , testosterone and prolactin. Exclusion criteria: any infection in genitourinary (GU) tract; any anatomical abnormality in GU tract such as varicocele , cryptorchidism; any chronic disease during last 3 months; any surgery on the testes and vas deferens; patients undergoing ICSI due to severe impairment sperm quality and the presence of other infertility factors, contact with pesticides, heavy metals and solvents; consumption of antioxidant supplements during last 3 months.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sperm motility. Timepoint: The beginning of the study , End of the study. Method of measurement: spermatogram. | — |
Secondary
| Measure | Time frame |
|---|---|
| Sex hormones. Timepoint: 12 weeks. Method of measurement: Eliza. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Hossein Khadem Haghighian
Qazvin University of Medical Sciences
Outcome results
None listed